Effect of Atorvastatin on Low-Density Lipoprotein Subfraction Profile

Rajman I Maxwell S Cramb R Kendall M. Particle size: The key to atherogenic lipoprotein? QJM 1994; 87: 709–20.

Packard CJ . LDL subfractions and atherogenicity: An hypothesis from the University of Glasgow. Curr Med Res Opin 1996; 13: 379–90.

Gaw A Packard CJ Caslake MJ Griffin BA Lindsay GM Thomson J Effects of ciprofibrate on LDL metabolism in man. Atherosclerosis 1994; 108: 137–48.

Shepherd J. Fibrates and statins in the treatment of hyperlipidaemia: An appraisal of their efficacy and safety. Eur Heart J 1995; 16: 5–13.

Bakker-Arkema RG Davidson MH Goldstein RJ Davignon J Isaacsohn JL Weiss SR Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia. JAMA 1996; 275: 128–33.

Rajman I Kendall MJ Cramb R Holder RL Salih M Gammage MD . Investigation of low density lipoprotein subfractions as a coronary risk factor in normotriglyceridaemic men. Atherosclerosis 1996; 125: 2311–242.